|
1
|
Semenas J, Allegrucci C, Boorjian SA, et
al: Overcoming drug resistance and treating advanced prostate
cancer. Curr Drug Targets. 13:1308–1323. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kohli M and Tindall DJ: New developments
in the medical management of prostate cancer. Mayo Clin Proc.
85:77–86. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Martin SK, Vaughan TB, Atkinson T, et al:
Emerging biomarkers of prostate cancer (Review). Oncol Rep.
28:409–417. 2012.PubMed/NCBI
|
|
4
|
Hilton WM, Padalecki SS, Ankerst DP, et
al: Temporal changes in the clinical approach to diagnosing
prostate cancer. J Natl Cancer Inst Monogr. 45:162–168. 2012.
View Article : Google Scholar
|
|
5
|
Paller CJ and Antonarakis ES: Management
of biochemically recurrent prostate cancer after local therapy:
evolving standards of care and new directions. Clin Adv Hematol
Oncol. 11:14–23. 2013.PubMed/NCBI
|
|
6
|
Khin-Maung U, Myo K, Nyunt-Nyunt W, et al:
Clinical trial of berberine in acute watery diarrhoea. Br Med J
(Clin Res Ed). 291:1601–1605. 1985. View Article : Google Scholar
|
|
7
|
Han J, Lin H and Huang W: Modulating gut
microbiota as an anti-diabetic mechanism of berberine. Med Sci
Monit. 17:RA164–167. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yin J, Zhang H and Ye J: Traditional
chinese medicine in treatment of metabolic syndrome. Endocr Metab
Immune Disord Drug Targets. 8:99–111. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liang KW, Ting CT, Yin SC, et al:
Berberine suppresses MEK/ERK-dependent Egr-1 signaling pathway and
inhibits vascular smooth muscle cell regrowth after in vitro
mechanical injury. Biochem Pharmacol. 71:806–817. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lin TH, Kuo HC, Chou FP, et al: Berberine
enhances inhibition of glioma tumor cell migration and invasiveness
mediated by arsenic trioxide. BMC Cancer. 8:582008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu B, Wang G, Yang J, et al: Berberine
inhibits human hepatoma cell invasion without cytotoxicity in
healthy hepatocytes. PLoS One. 6:e214162011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang L, Liu L, Shi Y, et al: Berberine
induces caspase-independent cell death in colon tumor cells through
activation of apoptosis-inducing factor. PLoS One. 7:e364182012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Piyanuch R, Sukhthankar M, Wandee G, et
al: Berberine, a natural isoquinoline alkaloid, induces NAG-1 and
ATF3 expression in human colorectal cancer cells. Cancer Lett.
258:230–240. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Park KS, Kim JB, Bae J, et al: Berberine
inhibited the growth of thyroid cancer cell lines 8505C and TPC1.
Yonsei Med J. 53:346–351. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fu L, Chen W, Guo W, et al: Berberine
targets AP-2/hTERT, NF-κB/COX-2, HIF-1α/VEGF and
cytochrome-C/caspase signaling to suppress human cancer cell
growth. PLoS One. 8:e692402013. View Article : Google Scholar
|
|
16
|
Wang L, Cao H, Lu N, et al: Berberine
inhibits proliferation and down-regulates epidermal growth factor
receptor through activation of Cbl in colon tumor cells. PLoS One.
8:e566662013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sun KK, Ji C, Li X, et al: Overexpression
of high mobility group protein B1 correlates with the proliferation
and metastasis of lung adenocarcinoma cells. Mol Med Rep.
7:1678–1682. 2013.PubMed/NCBI
|
|
18
|
Sun KK, Zhong N, Yang Y, et al: Enhanced
radiosensitivity of NSCLC cells by transducer of erbB2.1 (TOB1)
through modulation of the MAPK/ERK pathway. Oncol Rep.
29:2385–2391. 2013.PubMed/NCBI
|
|
19
|
Che J, Lu YW, Sun KK, et al:
Overexpression of TOB1 confers radioprotection to bronchial
epithelial cells through the MAPK/ERK pathway. Oncol Rep.
30:637–642. 2013.PubMed/NCBI
|
|
20
|
Li J, Cao B, Liu X, et al: Berberine
suppresses androgen receptor signaling in prostate cancer. Mol
Cancer Ther. 10:1346–1356. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vidal A and Koff A: Cell-cycle inhibitors:
three families united by a common cause. Gene. 247:1–15. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mantena SK, Sharma SD and Katiyar SK:
Berberine inhibits growth, induces G1 arrest and apoptosis in human
epidermoid carcinoma A431 cells by regulating Cdki-Cdk-cyclin
cascade, disruption of mitochondrial membrane potential and
cleavage of caspase 3 and PARP. Carcinogenesis. 27:2018–2027. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chidambara Murthy KN, Jayaprakasha GK and
Patil BS: The natural alkaloid berberine targets multiple pathways
to induce cell death in cultured human colon cancer cells. Eur J
Pharmacol. 688:14–21. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Okada H and Mak TW: Pathways of apoptotic
and non-apoptotic death in tumour cells. Nat Rev Cancer. 4:592–603.
2004. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Patil JB, Kim J and Jayaprakasha GK:
Berberine induces apoptosis in breast cancer cells (MCF-7) through
mitochondrial-dependent pathway. Eur J Pharmacol. 645:70–78. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Prenzel N, Fischer OM, Streit S, et al:
The epidermal growth factor receptor family as a central element
for cellular signal transduction and diversification. Endocr Relat
Cancer. 8:11–31. 2001. View Article : Google Scholar : PubMed/NCBI
|
